Variant report

Variant	nsv594821
Chromosome Location	chr4:90871561-90962886
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:90915498-90916168	HepG2	liver:	n/a	n/a
2	ATF2	chr4:90948720-90949133	GM12878	blood:	n/a	n/a
3	BCL11A	chr4:90948754-90949039	GM12878	blood:	n/a	n/a
4	BCL11A	chr4:90948808-90949047	GM12878	blood:	n/a	n/a
5	BCL11A	chr4:90949609-90950037	GM12878	blood:	n/a	n/a
6	BHLHE40	chr4:90949419-90950090	GM12878	blood:	n/a	n/a
7	CEBPB	chr4:90929334-90929504	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr4:90909376-90909718	IMR90	lung:	n/a	n/a
9	CEBPB	chr4:90906567-90906708	HepG2	liver:	n/a	chr4:90906618-90906629
10	CEBPB	chr4:90919059-90919307	HepG2	liver:	n/a	chr4:90919170-90919181
11	CEBPB	chr4:90909411-90909641	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr4:90876104-90876433	HepG2	liver:	n/a	n/a
13	CEBPB	chr4:90909420-90909712	A549	lung:	n/a	n/a
14	CEBPB	chr4:90882186-90882605	H1-hESC	embryonic stem cell:	n/a	n/a
15	CEBPB	chr4:90902659-90902905	HepG2	liver:	n/a	chr4:90902759-90902770
16	CEBPB	chr4:90906484-90906786	H1-hESC	embryonic stem cell:	n/a	chr4:90906618-90906629
17	CEBPB	chr4:90876186-90876409	A549	lung:	n/a	n/a
18	CEBPB	chr4:90919118-90919279	A549	lung:	n/a	chr4:90919170-90919181
19	CEBPB	chr4:90909401-90909715	HepG2	liver:	n/a	n/a
20	CEBPB	chr4:90919047-90919294	IMR90	lung:	n/a	chr4:90919170-90919181
21	CEBPB	chr4:90912487-90912734	HepG2	liver:	n/a	chr4:90912607-90912618 chr4:90912604-90912621
22	CEBPB	chr4:90876132-90876407	IMR90	lung:	n/a	n/a
23	CEBPB	chr4:90912492-90912717	A549	lung:	n/a	chr4:90912607-90912618 chr4:90912604-90912621
24	CEBPB	chr4:90876134-90876426	H1-hESC	embryonic stem cell:	n/a	n/a
25	CEBPB	chr4:90915689-90916023	HepG2	liver:	n/a	n/a
26	CEBPB	chr4:90919120-90919207	H1-hESC	embryonic stem cell:	n/a	chr4:90919170-90919181
27	CHD2	chr4:90948731-90949063	GM12878	blood:	n/a	n/a
28	CHD2	chr4:90949359-90950066	GM12878	blood:	n/a	n/a
29	CTCF	chr4:90919666-90919774	HUVEC	blood vessel:	n/a	chr4:90919698-90919716 chr4:90919693-90919714
30	CTCF	chr4:90946440-90946590	GM12878	blood:	n/a	n/a
31	CTCF	chr4:90946480-90946630	GM12872	blood:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
32	CTCF	chr4:90946480-90946630	HRPEpiC	eye:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
33	CTCF	chr4:90952260-90952410	HRE	kidney:	n/a	chr4:90952304-90952325 chr4:90952302-90952320
34	CTCF	chr4:90952280-90952430	HCT-116	colon:	n/a	chr4:90952304-90952325 chr4:90952302-90952320
35	CTCF	chr4:90946467-90946679	H1-hESC	embryonic stem cell:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
36	CTCF	chr4:90919600-90919750	HAc	cerebellar:	n/a	chr4:90919698-90919716 chr4:90919693-90919714
37	CTCF	chr4:90946560-90946710	GM12872	blood:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
38	CTCF	chr4:90952300-90952450	HA-sp	spinal cord:	n/a	chr4:90952304-90952325 chr4:90952302-90952320
39	CTCF	chr4:90946480-90946630	GM12866	blood:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
40	CTCF	chr4:90946520-90946670	HRE	kidney:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
41	CTCF	chr4:90946500-90946650	BE2_C	brain:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
42	CTCF	chr4:90934900-90934974	GM20000	blood:	n/a	n/a
43	CTCF	chr4:90946420-90946570	HRPEpiC	eye:	n/a	n/a
44	CTCF	chr4:90952114-90952447	H1-hESC	embryonic stem cell:	n/a	chr4:90952304-90952325 chr4:90952302-90952320
45	CTCF	chr4:90952240-90952390	HEEpiC	esophagus:	n/a	chr4:90952304-90952325 chr4:90952302-90952320
46	CTCF	chr4:90952220-90952370	Hela-S3	cervix:	n/a	chr4:90952304-90952325 chr4:90952302-90952320
47	CTCF	chr4:90946520-90946670	HPF	lung:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
48	CTCF	chr4:90946431-90946623	A549	lung:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
49	CTCF	chr4:90946500-90946650	HCM	heart:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598
50	CTCF	chr4:90946490-90946658	A549	lung:	n/a	chr4:90946582-90946600 chr4:90946583-90946599 chr4:90946584-90946605 chr4:90946585-90946598

No.	Distal block	Cell Line	Cell type
1	chr4:90931435..90933735-chr4:90933990..90936566,2	MCF-7	breast:
2	chr4:90949251..90952880-chr4:91047534..91049832,6	MCF-7	breast:
3	chr4:90923727..90925753-chr4:91047906..91049514,2	MCF-7	breast:
4	chr4:90953266..90956083-chr4:91047299..91049522,2	MCF-7	breast:
5	chr4:90960071..90961851-chr4:91048286..91050197,2	MCF-7	breast:
6	chr4:90931435..90933735-chr4:90933990..90936566,2	MCF-7	breast:
7	chr4:90950024..90952887-chr4:91047925..91049735,3	MCF-7	breast:
8	chr4:90952233..90952750-chr4:91214459..91215033,2	MCF-7	breast:
9	chr4:90956253..90958836-chr4:91048195..91050862,3	MCF-7	breast:
10	chr4:90953032..90955115-chr4:91047957..91050327,2	MCF-7	breast:

Variant related genes	Relation type
MMRN1	TF binding region
ENSG00000184305	chromatin interactions

Extended variants
information (count: 2429 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:2429 , 50 per page) page: 1 2 3 4 5 6 7 ... 49

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6854896	chr4:90871561-90871562	Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs140294584	chr4:90871562-90871563	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs535887976	chr4:90871575-90871576	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs549198322	chr4:90871585-90871586	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs569365565	chr4:90871602-90871603	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs538422186	chr4:90871607-90871608	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs1479429	chr4:90871662-90871663	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs80321122	chr4:90871663-90871664	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs67165846	chr4:90871680-90871681	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs188039353	chr4:90871739-90871740	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs1479428	chr4:90871814-90871815	Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs541851646	chr4:90871815-90871816	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs555155798	chr4:90871816-90871817	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs568630982	chr4:90871829-90871830	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs369700919	chr4:90871835-90871836	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs575318895	chr4:90871837-90871838	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs543966801	chr4:90871878-90871879	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs563948698	chr4:90871894-90871895	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs146430136	chr4:90871924-90871925	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs562408335	chr4:90871933-90871934	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs560434631	chr4:90871965-90871966	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs149106586	chr4:90871980-90871981	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs577920983	chr4:90872033-90872034	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs558476967	chr4:90872039-90872040	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs549384695	chr4:90872091-90872092	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs34867040	chr4:90872134-90872135	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs190908043	chr4:90872142-90872143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs62312664	chr4:90872163-90872164	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs551966463	chr4:90872249-90872250	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs182371938	chr4:90872252-90872253	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs116738462	chr4:90872284-90872285	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs554160916	chr4:90872308-90872309	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs151005856	chr4:90872310-90872311	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs567985050	chr4:90872327-90872328	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs114276116	chr4:90872364-90872365	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs143204781	chr4:90872389-90872390	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs186614780	chr4:90872390-90872391	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs575209540	chr4:90872460-90872461	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs543905836	chr4:90872463-90872464	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs6813151	chr4:90872501-90872502	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs148244774	chr4:90872516-90872517	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs540068844	chr4:90872551-90872552	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs560163412	chr4:90872578-90872579	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs529211825	chr4:90872580-90872581	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs542622420	chr4:90872584-90872585	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs562913822	chr4:90872609-90872610	Active TSS Strong transcription Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs531794980	chr4:90872610-90872611	Active TSS Strong transcription Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs140349895	chr4:90872611-90872612	Active TSS Strong transcription Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs571810464	chr4:90872635-90872636	Active TSS Strong transcription Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs527873702	chr4:90872671-90872672	Active TSS Strong transcription Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	18414403	CNVD
primary effusion lymphomas	17116491	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Olfactory neuroblastoma	18408657	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
Acute monocytic leukemia	16498392	CNVD
Multiple myeloma	16616336	CNVD
Esophageal adenocarcinoma	18820669	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Parkinson disease	20877625	CNVD
Hirschsprung''s Disease	21712996	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Obesity	20622171	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Parkinson disease	17953491	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:270 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:90855000-90872400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
2	chr4:90856800-90878200	Weak transcription	Primary hematopoietic stem cells	blood
3	chr4:90859200-90872600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr4:90861400-90872400	Weak transcription	HUVEC	blood vessel
5	chr4:90867400-90872400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr4:90868400-90875600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
7	chr4:90872000-90872800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr4:90872200-90872400	Enhancers	iPS-20b Cell Line	embryonic stem cell
9	chr4:90872400-90872800	Active TSS	iPS-15b Cell Line	embryonic stem cell
10	chr4:90872400-90872800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
11	chr4:90872400-90873600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr4:90872400-90873800	Enhancers	HUES48 Cell Line	embryonic stem cell
13	chr4:90872400-90874000	Enhancers	HUES6 Cell Line	embryonic stem cell
14	chr4:90872400-90874000	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr4:90872400-90874200	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr4:90872400-90876800	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr4:90872400-90876800	Strong transcription	HUVEC	blood vessel
18	chr4:90872600-90872800	Active TSS	ES-I3 Cell Line	embryonic stem cell
19	chr4:90872600-90873600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
20	chr4:90872800-90873000	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
21	chr4:90872800-90874000	Enhancers	iPS-15b Cell Line	embryonic stem cell
22	chr4:90872800-90874000	Enhancers	iPS-20b Cell Line	embryonic stem cell
23	chr4:90872800-90878600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
24	chr4:90873000-90873800	Enhancers	ES-I3 Cell Line	embryonic stem cell
25	chr4:90873600-90873800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr4:90873600-90873800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr4:90873600-90874600	Genic enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr4:90873800-90874600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr4:90873800-90876200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
30	chr4:90873800-90876200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr4:90873800-90878200	Weak transcription	HUES48 Cell Line	embryonic stem cell
32	chr4:90874000-90874200	Enhancers	H1 Cell Line	embryonic stem cell
33	chr4:90874000-90877800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
34	chr4:90874000-90878200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
35	chr4:90874000-90878400	Weak transcription	HUES6 Cell Line	embryonic stem cell
36	chr4:90874000-90878400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
37	chr4:90874200-90876400	Weak transcription	H1 Cell Line	embryonic stem cell
38	chr4:90874200-90878200	Weak transcription	HUES64 Cell Line	embryonic stem cell
39	chr4:90874600-90875200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr4:90874600-90876200	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr4:90875200-90876400	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr4:90875400-90878200	Enhancers	Primary neutrophils fromperipheralblood	blood
43	chr4:90876200-90876400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
44	chr4:90876200-90876600	Enhancers	ES-I3 Cell Line	embryonic stem cell
45	chr4:90876200-90876800	Genic enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr4:90876400-90876600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
47	chr4:90876400-90876600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
48	chr4:90876400-90876600	Genic enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr4:90876400-90876800	Enhancers	H1 Cell Line	embryonic stem cell
50	chr4:90876600-90876800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links